These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Other 2004-002306-29 Psoriasis, Folic Acid Supplementation and Plasma Homocysteine Levels not-yet-due
Reported results 2005-000106-31 IMPACT OF CYP2D6, SEROTONIN TRANSPORTER, 5HT1, 5HT2 AND 5HT3 RECEPTOR AND MU RECEPTOR GENE POLYMORPHISMS ON EFFICACY AND TOXICITY OF TRAMADOL 2007-12-20 due-trials
Reported results 2005-000619-85 The relationship between genetic polymorphisms in the organic cation transporter genes and the pharmacokinetics and pharmacodynamics of metformin 2009-05-01 due-trials
Not reported Terminated 2005-003824-21 Effects and comparisons of once & twice daily insulin’s in combination with oral hypoglycaemic agents on glycaemic control, hypoglycaemia and weight in type 2 Diabetes. 2011-01-25 due-trials
Reported results 2005-004316-73 The effects of growth hormone, strontium ranelate and phosphate on PTH circadian rhythm, PTH target organ sensitivity, bone turnover markers, phospho-calcium metabolism and bone mineral density. A pro... 2012-09-25 due-trials
Other 2006-000087-83 EUROPAC2 trial to investigate the efficacy of ANTOX(vers) 1.2 and MGCT (magnesiocard) for the treatment of hereditary pancreatitis and idiopathic chronic pancreatitis. not-yet-due
Reported results 2006-000461-10 A prospective, phase III, controlled, multicentre, randomised clinical trial comparing combination gemcitabine and capecitabine therapy with concurrent and sequential chemoimmunotherapy using a telome... 2016-06-29 due-trials
Reported results 2006-006076-38 The Liverpool HIV TDM Registry: Studying influences upon plasma HIV drug exposure 2015-12-30 due-trials
Reported results Terminated 2007-000379-41 Liverpool Avastin Dose Response and Retreatment Study 2010-11-19 due-trials
Ongoing 2007-004299-38 European Study Group for Pancreatic Cancer - Trial 4. Combination versus single agent adjuvant chemotherapy in resectable pancreatic cancer. not-yet-due
Reported results 2008-001137-99 CHANGE TO: A PILOT RANDOMISED STUDY TO COMPARE COMBINATION ANTIBIOTIC THERAPY (CIPROFLOXACIN AND DOXYCYCLINE) WITH STANDARD THERAPY (BUDESONIDE) IN THE TREATMENT OF ACTIVE CROHN'S DISEASE 2019-05-30 due-trials
Reported results Terminated 2008-002627-90 Intracellular boosting of HIV protease inhibitors through inhibition of transport - a novel strategy for potentiating HIV therapy 2012-02-29 due-trials
Other 2008-004759-31 Purine-Alkylator Combination In Follicular lymphoma Immuno-Chemotherapy for Older patients: a phase III comparison of first-line R-CVP versus R-FC lite not-yet-due
Reported results Terminated 2008-006371-67 EFFECT OF THIENOPYRIDINE DERIVATIVE (CLOPIDOGREL) ON THE DISPOSITION OF EFAVIRENZ AND NEVIRAPINE IN HIV POSITIVE PATIENTS 2012-12-14 due-trials
Reported results 2009-013798-16 A comparison of plerixafor/G-CSF with chemotherapy/G-CSF for stem cell transplantation 2013-09-12 due-trials
Reported results 2010-019575-29 Phase II trial of ofatumumab, dexamethasone and lenalidomide for high-risk CLL (NCRI CLL210) 2017-04-07 due-trials
Reported results 2010-021951-26 VIP: A prospective, phase II, double blinded, multicentre, randomised clinical trial comparing combination gemcitabine and vandetanib therapy with gemcitabine therapy alone in locally advanced or meta... 2018-09-05 due-trials
Reported results Terminated 2011-000961-10 Neoadjuvant IntraviTreal Ranibizumab treatment in high risk Ocular melanoma patients: A two stage single centre Phase II single arm study (NITRO Trial) 2014-10-17 due-trials
Other 2011-002466-20 An exploratory, randomised, 3-way crossover study to determine the effect of paracetamol on urinary cystine excretion in cystinuria not-yet-due
Other 2011-006084-22 Utilising drug levels and anti-drug antibodies to predict response to treatment in patients with Inflammatory Bowel Disease not-yet-due
Reported results 2012-000935-18 TAILoR – (TelmisArtan and InsuLin Resistance in HIV): A Dose-Ranging Phase II Randomised Open-Labelled Trial of Telmisartan as a strategy for the Reduction of Insulin Resistance in HIV-Positive Indivi... 2017-06-08 due-trials
Reported results 2012-004025-24 A trial of de-escalation and stopping treatment in chronic myeloid leukaemia patients with excellent responses to tyrosine kinase inhibitor therapy DESTINY(De- Escalation and Stopping Treatment of Im... 2018-08-01 due-trials
Reported results 2012-005141-20 FULL TITLE: Pneumococcal Conjugate Vaccine (PCV-13) and Experimental Human Pneumococcal Carriage Study (EHPC) Study. KEY WORDS: mucosa, innate, cellular, humoral, Streptococcus pneumoniae, pneumococcu... 2014-11-07 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-003932-56 ESPAC-5F: European Study Group for Pancreatic Cancer - Trial 5F Four arm, prospective, multicentre, randomised feasibility trial of immediate surgery compared with neoadjuvant chemotherapies and neo... 2021-02-03 bad-data
Reported results 2014-004634-26 The Effect of Live Attenuated Influenza Vaccine (LAIV) on Experimental Human Pneumococcal Colonisation (EHPC) Study 2017-04-30 due-trials
Other 2018-002982-20 A Pilot Study to assess the efficacy and safety of reduced dose oral iron in the treatment of iron deficiency anaemia in inflammatory bowel disease patients not-yet-due